Jörg Vogel and Linda Popella are redsearching a new class of antibiotics.
Jörg Vogel and Linda Popella are redsearching a new class of antibiotics. Similar to the vaccines against the coronavirus, RNA-based antibiotics could significantly improve modern medicine. Research teams from Würzburg have investigated the prerequisites that such antibiotics must meet for this strategy to work. In the fight against the Covid-19 pandemic, mRNA-based vaccines have impressively demonstrated their potential. Using this technology, scientists were able to rapidly develop and bring to market vaccines against SARS-CoV-2 that have been extremely effective at protecting millions of people against severe disease progression of COVID-19 or even death. However, RNA-based medicine can be used to combat more than just viruses. Among others, it can also be considered as a candidate for a new type of antibiotics that can be used to treat bacterial infections in a tailored manner.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
